Memantine leading to physical aggression in the treatment of chronic catatonia secondary to schizophrenia: A case report
Introduction Memantine is a noncompetitive N-methyl-D-aspartate receptor antagonist approved by the FDA for moderate to severe Alzheimer’s dementia. Memantine is also recommended as an off-label treatment in current catatonia clinical guidelines when benzodiazepines alone are inadequate. Case A 37-y...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Association of Psychiatric Pharmacists
2025-08-01
|
| Serija: | Mental Health Clinician |
| Teme: | |
| Online dostop: | https://theijpt.org/doi/pdf/10.9740/mhc.2025.08.218 |
| Oznake: |
Brez oznak, prvi označite!
|